Polatuzumab vedotin

Polatuzumab vedotin, also known as Polivy, is a targeted medicine used to treat specific types of B-cell lymphoma, a cancer that starts in certain white blood cells. It's given into a vein through an IV infusion. This medicine works by finding a particular protein on lymphoma cells and then delivering a chemotherapy drug directly inside them. This focused approach helps to stop the growth of cancer cells while aiming to protect healthy cells. In this topic, you can learn more about how Polivy works as part of your treatment plan, what to expect, and ways to manage any side effects.